BioCentury
ARTICLE | Company News

Dyax, Becton in antibody deal

June 13, 2001 7:00 AM UTC

The companies will discovery antibodies using DYAX's phage display technology. BDX has exclusive rights to market resulting antibodies to the life sciences market as research products, while DYAX reta...